Cargando…
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470677/ https://www.ncbi.nlm.nih.gov/pubmed/37663673 http://dx.doi.org/10.1097/HS9.0000000000000940 |
| _version_ | 1785099732828291072 |
|---|---|
| author | Groen, Kazimierz Schjesvold, Fredrik H. van der Holt, Bronno Levin, Mark-David Seefat, Maarten R. Hansson, Markus Leys, Maria B.L. Regelink, Josien C. Waage, Anders Szatkowski, Damian Axelsson, Per Hieu Do, Trung Svirskaite, Asta van der Spek, Ellen Haukas, Einar Knut-Bojanowska, Dorota Ypma, Paula F. Blimark, Cecilie H. Mellqvist, Ulf-Henrik van de Donk, Niels W.C.J. Sonneveld, Pieter Klostergaard, Anja Vangsted, Annette J. Abildgaard, Niels Zweegman, Sonja |
| author_facet | Groen, Kazimierz Schjesvold, Fredrik H. van der Holt, Bronno Levin, Mark-David Seefat, Maarten R. Hansson, Markus Leys, Maria B.L. Regelink, Josien C. Waage, Anders Szatkowski, Damian Axelsson, Per Hieu Do, Trung Svirskaite, Asta van der Spek, Ellen Haukas, Einar Knut-Bojanowska, Dorota Ypma, Paula F. Blimark, Cecilie H. Mellqvist, Ulf-Henrik van de Donk, Niels W.C.J. Sonneveld, Pieter Klostergaard, Anja Vangsted, Annette J. Abildgaard, Niels Zweegman, Sonja |
| author_sort | Groen, Kazimierz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10470677 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104706772023-09-01 Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13 Groen, Kazimierz Schjesvold, Fredrik H. van der Holt, Bronno Levin, Mark-David Seefat, Maarten R. Hansson, Markus Leys, Maria B.L. Regelink, Josien C. Waage, Anders Szatkowski, Damian Axelsson, Per Hieu Do, Trung Svirskaite, Asta van der Spek, Ellen Haukas, Einar Knut-Bojanowska, Dorota Ypma, Paula F. Blimark, Cecilie H. Mellqvist, Ulf-Henrik van de Donk, Niels W.C.J. Sonneveld, Pieter Klostergaard, Anja Vangsted, Annette J. Abildgaard, Niels Zweegman, Sonja Hemasphere Letter Lippincott Williams & Wilkins 2023-08-30 /pmc/articles/PMC10470677/ /pubmed/37663673 http://dx.doi.org/10.1097/HS9.0000000000000940 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article distributed under the Creative Commons Attribution-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nd/4.0/) , which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. |
| spellingShingle | Letter Groen, Kazimierz Schjesvold, Fredrik H. van der Holt, Bronno Levin, Mark-David Seefat, Maarten R. Hansson, Markus Leys, Maria B.L. Regelink, Josien C. Waage, Anders Szatkowski, Damian Axelsson, Per Hieu Do, Trung Svirskaite, Asta van der Spek, Ellen Haukas, Einar Knut-Bojanowska, Dorota Ypma, Paula F. Blimark, Cecilie H. Mellqvist, Ulf-Henrik van de Donk, Niels W.C.J. Sonneveld, Pieter Klostergaard, Anja Vangsted, Annette J. Abildgaard, Niels Zweegman, Sonja Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13 |
| title | Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13 |
| title_full | Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13 |
| title_fullStr | Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13 |
| title_full_unstemmed | Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13 |
| title_short | Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13 |
| title_sort | ixazomib-thalidomide-dexamethasone induction followed by ixazomib or placebo maintenance in nontransplant eligible newly diagnosed multiple myeloma patients: long-term results of hovon-126/nmsg 21.13 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470677/ https://www.ncbi.nlm.nih.gov/pubmed/37663673 http://dx.doi.org/10.1097/HS9.0000000000000940 |
| work_keys_str_mv | AT groenkazimierz ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT schjesvoldfredrikh ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT vanderholtbronno ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT levinmarkdavid ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT seefatmaartenr ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT hanssonmarkus ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT leysmariabl ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT regelinkjosienc ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT waageanders ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT szatkowskidamian ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT axelssonper ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT hieudotrung ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT svirskaiteasta ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT vanderspekellen ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT haukaseinar ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT knutbojanowskadorota ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT ypmapaulaf ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT blimarkcecilieh ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT mellqvistulfhenrik ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT vandedonknielswcj ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT sonneveldpieter ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT klostergaardanja ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT vangstedannettej ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT abildgaardniels ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT zweegmansonja ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 |